ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FBIO Fortress Biotech Inc

2.1185
0.1385 (6.99%)
Last Updated: 14:24:45
Delayed by 15 minutes

Period:

Draw Mode:

Volume 751,598
Bid Price 2.11
Ask Price 2.12
News -
Day High 2.28

Low
1.24

52 Week Range

High
12.75

Day Low 1.97
Company Name Stock Ticker Symbol Market Type
Fortress Biotech Inc FBIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.1385 6.99% 2.1185 14:24:45
Open Price Low Price High Price Close Price Prev Close
1.97 1.97 2.28 1.98
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,478 751,598 $ 2.13 $ 1,598,374 - 1.24 - 12.75
Last Trade Time Type Quantity Stock Price Currency
14:24:45 1,000 $ 2.1185 USD

Fortress Biotech Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
18.87M 8.94M - 75.74M -86.58M -9.68 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Fortress Biotech News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No FBIO Message Board. Create One! See More Posts on FBIO Message Board See More Message Board Posts

Historical FBIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.772.281.6851.84245,3180.348519.69%
1 Month2.012.281.631.84300,4850.10855.40%
3 Months2.694.431.632.49577,109-0.5715-21.25%
6 Months5.976.2551.242.82568,643-3.85-64.51%
1 Year12.3012.751.246.19591,110-10.18-82.78%
3 Years56.2591.501.2431.93656,422-54.13-96.23%
5 Years32.1091.501.2435.63673,748-29.98-93.40%

Fortress Biotech Description

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Your Recent History

Delayed Upgrade Clock